Sulayman D Dib-Hajj Selected Research

Channelopathies

1/2019	NaV 1.6 regulates excitability of mechanosensitive sensory neurons.
11/2014	Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.
8/2010	A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons.
6/2010	Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia.
6/2005	Erythromelalgia: a hereditary pain syndrome enters the molecular era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sulayman D Dib-Hajj Research Topics

Disease

68	Pain (Aches) 12/2024 - 06/2005
30	Erythromelalgia (Erythermalgia) 12/2023 - 09/2004
19	Neuralgia (Stump Neuralgia) 01/2024 - 10/2003
10	Chronic Pain 01/2018 - 06/2005
8	Peripheral Nervous System Diseases (PNS Diseases) 03/2024 - 06/2014
7	Paroxysmal Extreme Pain Disorder 12/2023 - 09/2008
7	Small Fiber Neuropathy 01/2023 - 11/2012
5	Hyperalgesia 03/2024 - 02/2010
5	Channelopathies 01/2019 - 06/2005
4	Painful Neuropathy 06/2014 - 09/2004
3	Congenital Pain Insensitivity 01/2020 - 06/2010
3	Brain Diseases (Brain Disorder) 05/2016 - 09/2014
3	Epilepsy (Aura) 09/2014 - 08/2010
2	Nervous System Diseases (Neurological Disorders) 11/2022 - 03/2012
2	Trigeminal Neuralgia (Tic Douloureux) 02/2021 - 01/2020
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2015 - 02/2012
2	Multiple Sclerosis 01/2015 - 02/2012
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2015 - 02/2012
2	Inflammation (Inflammations) 10/2013 - 11/2012
1	Neoplasms (Cancer) 01/2023
1	Hypesthesia (Numbness) 01/2023
1	Acute Pain 01/2020
1	Nerve Degeneration 01/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 11/2018
1	Kidney Calculi (Kidney Stone) 07/2018
1	Somatoform Disorders (Somatoform Disorder) 01/2017
1	Movement Disorders (Movement Disorder) 05/2016
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 07/2015
1	Guillain-Barre Syndrome 07/2015
1	Infantile Epileptic-Dyskinetic Encephalopathy 05/2015
1	Intellectual Disability (Idiocy) 05/2015
1	Polyneuropathies (Polyneuropathy) 01/2015
1	Ataxia (Dyssynergia) 01/2015
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 09/2014

Drug/Important Bio-Agent (IBA)

64	Sodium Channels (Sodium Channel)IBA 03/2024 - 10/2003
33	Voltage-Gated Sodium ChannelsIBA 03/2024 - 08/2004
11	Ion Channels (Ion Channel)IBA 01/2023 - 06/2005
7	Protein Isoforms (Isoforms)IBA 11/2020 - 04/2009
6	SodiumIBA 01/2023 - 06/2010
6	Carbamazepine (Tegretol)FDA LinkGeneric 11/2018 - 06/2009
5	Tetrodotoxin (Tetradotoxin)IBA 03/2024 - 09/2004
5	Sodium Channel BlockersIBA 01/2019 - 10/2009
4	Proteins (Proteins, Gene)FDA Link 12/2024 - 01/2015
3	Analgesics (Analgesic Drugs)IBA 11/2020 - 01/2017
3	Amino Acids FDA Link 05/2016 - 11/2006
2	Vincristine (Oncovin)FDA LinkGeneric 03/2024 - 01/2020
2	CannabinoidsIBA 01/2024 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2020
2	Peptides (Polypeptides)IBA 01/2023 - 04/2012
2	Lacosamide FDA Link 01/2020 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2013 - 02/2010
1	Monomeric GTP-Binding ProteinsIBA 01/2023
1	Cystine-Knot MiniproteinsIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Scorpion Venoms (Scorpion Venom)IBA 01/2022
1	cannabigerolIBA 01/2022
1	Calcium Gluconate (CBG)IBA 01/2022
1	CytokinesIBA 10/2021
1	Protein Kinases (Protein Kinase)IBA 10/2021
1	CationsIBA 02/2021
1	Menthol FDA Link 02/2021
1	Naloxone (Narcan)FDA LinkGeneric 01/2020
1	benzothiazoleIBA 01/2020
1	Transient Receptor Potential ChannelsIBA 01/2020
1	SR 144528IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	RimonabantIBA 01/2020
1	Cannabinoid Receptor AntagonistsIBA 01/2020
1	DexpramipexoleIBA 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2020
1	NAV1.7 Voltage-Gated Sodium ChannelIBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	CarrageenanIBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Aspartic Acid (Aspartate)FDA Link 01/2017
1	AutoantibodiesIBA 07/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2015
1	Arginine (L-Arginine)FDA Link 06/2015
1	6- amino- 5- (2,3,5- trichlorophenyl)pyridine- 2- carboxylic acid methylamideIBA 01/2015
1	Nodal ProteinIBA 01/2015
1	AntibodiesIBA 01/2015
1	Mutant Proteins (Protein, Mutant)IBA 11/2014
1	Lamotrigine (Lamictal)FDA LinkGeneric 10/2014
1	DNA (Deoxyribonucleic Acid)IBA 09/2014
1	Messenger RNA (mRNA)IBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 08/2014
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2013
1	Nerve Growth Factor (NGF)IBA 10/2013

Therapy/Procedure

11	Therapeutics 01/2023 - 04/2009
9	Drug Therapy (Chemotherapy) 01/2023 - 01/2010
1	Refractive Surgical Procedures 01/2023
1	Axotomy 01/2023
1	Analgesia 01/2020
1	Anesthesia 01/2018
1	Precision Medicine 01/2018
1	Oral Administration 01/2015
1	Complementary Therapies (Alternative Medicine) 08/2014
1	Intradermal Injections 10/2013